[HTML][HTML] Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations

R Varela-Fernández, V Díaz-Tomé… - Pharmaceutics, 2020 - mdpi.com
The treatment of the posterior-segment ocular diseases, such as age-related eye diseases
(AMD) or diabetic retinopathy (DR), present a challenge for ophthalmologists due to the …

[HTML][HTML] Pharmacokinetic aspects of retinal drug delivery

EM Del Amo, AK Rimpelä, E Heikkinen, OK Kari… - Progress in retinal and …, 2017 - Elsevier
Drug delivery to the posterior eye segment is an important challenge in ophthalmology,
because many diseases affect the retina and choroid leading to impaired vision or …

[HTML][HTML] Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data

EM Del Amo, A Urtti - Experimental eye research, 2015 - Elsevier
Intravitreal administration is the method of choice in drug delivery to the retina and/or
choroid. Rabbit is the most commonly used animal species in intravitreal pharmacokinetics …

Endophthalmitis

MS Kresloff, AA Castellarin, MA Zarbin - Survey of ophthalmology, 1998 - Elsevier
Endophthalmitis is an inflammatory reaction of intraocular fluids or tissues. Infectious
endophthalmitis is one of the most serious complications of ophthalmic surgery …

Endophthalmitis: a review of current evaluation and management

CA Lemley, DP Han - Retina, 2007 - journals.lww.com
Purpose: To review the current state of evaluation and management of various forms of
endophthalmitis. Methods: A review of the literature is included, encompassing …

Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development

EM Del Amo, KS Vellonen, H Kidron, A Urtti - European Journal of …, 2015 - Elsevier
The aims of this research were to (1) create a curated universal database of intravitreal
volumes of distribution (V ss, ivt) and clearances (CL ivt) of small molecular weight …

[HTML][HTML] Alternative routes of administration for therapeutic antibodies—state of the art

A Pitiot, N Heuzé-Vourc'h, T Sécher - Antibodies, 2022 - mdpi.com
Background: For the past two decades, there has been a huge expansion in the
development of therapeutic antibodies, with 6 to 10 novel entities approved each year …

Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes

M Edington, J Connolly, NV Chong - Expert opinion on drug …, 2017 - Taylor & Francis
Introduction: The review aims to discuss effects of vitrectomy on pharmacokinetics of anti-
vascular endothelial growth factor (anti-VEGF) agents, and attempt to provide treatment …

Management of bacterial postoperative endophthalmitis and the role of vitrectomy

B Clarke, TH Williamson, G Gini, B Gupta - Survey of Ophthalmology, 2018 - Elsevier
Management of postoperative bacterial endophthalmitis was explored in the
Endophthalmitis Vitrectomy Study 37 in 1995, which has underpinned the core protocols in …

[HTML][HTML] The role of systemic antimicrobials in the treatment of endophthalmitis: a review and an international perspective

A Grzybowski, M Turczynowska, SG Schwartz… - Ophthalmology and …, 2020 - Springer
Background The optimal management of patients with endophthalmitis is challenging and
includes both intravitreal and, in some cases, systemic antimicrobials. Systemic …